Peripheral Neuritis Treatment Market Segmentation:
Route of Administration Segment Analysis
Oral treatment modalities are expected to have a gain of 62% share of the route of administration segment in the market by the forecast period. According to the NLM September 2024 report, for the patient groups studied, it was noted that the incidence of CIPN was approximately 68.1% in the first month post-chemotherapy, 60.0% in three months, and 30.0% in six months. These observations underscore the need for CIPN management to be included in clinical treatment protocols and draw attention to the need for appropriate treatment methods on the part of clinicians and pharmaceutical distributors. This is further driven by patient preference for non-invasive therapies and the ease of adherence associated with oral dosing.
Drug Class Segment Analysis
Antiepileptics are expected to gain 34% market share by 2035 in the drug-class segment of peripheral neuritis treatment market. The clinical utility to relieve neuropathic pain, especially chemo-induced and diabetic peripheral neuropathy, leads to the consistent demand for it. Gabapentin and pregabalin continue to dominate the market, as these agents have consistently been added to many formularies and purchased by hospitals, giving anticonvulsants a strategic subsegment for pharmaceutical alliances and market penetration. Increasing clinical endorsements and cost-effectiveness further strengthen the role of antiepileptics in long-term neuropathic pain management.
Application Segment Analysis
The diabetic peripheral neuropathy sub-segment is expected to hold 35% of the market share in 2035. The growth is driven by the trending increase in the global price of diabetes, an aging population, and targeted therapeutics. Stakeholders tend to increasingly put emphasis on strategic alliances and portfolio extension to capture the B2B market segment with high growth opportunities for chronic neuropathic care. Rising healthcare investments and early diagnosis initiatives are also contributing to the sustained expansion of this sub-segment.
Our in-depth analysis of the global peripheral neuritis treatment market includes the following segments:
|
Segment |
Sub-segments |
|
Type |
|
|
Therapeutic Method |
|
|
Route of Administration |
|
|
Drug Class |
|
|
Application |
|
|
Distribution Channel |
|
